PagnatoKarp Partners’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-6,228
| Closed | -$300K | – | 54 |
|
|
2020
Q1 | $300K | Sell |
6,228
-285
| -4% | -$13.7K | 0.07% | 125 |
|
|
2019
Q4 | $387K | Hold |
6,513
| – | – | 0.07% | 137 |
|
|
2019
Q3 | $351K | Sell |
6,513
-175
| -3% | -$9.43K | 0.07% | 139 |
|
|
2019
Q2 | $338K | Buy |
6,688
+781
| +13% | +$39.5K | 0.07% | 138 |
|
|
2019
Q1 | $313K | Buy |
5,907
+329
| +6% | +$17.4K | 0.07% | 131 |
|
|
2018
Q4 | $270K | Sell |
5,578
-720
| -11% | -$34.9K | 0.06% | 122 |
|
|
2018
Q3 | $320K | Sell |
6,298
-5,625
| -47% | -$286K | 0.09% | 115 |
|
|
2018
Q2 | $608K | Sell |
11,923
-3
| -0% | -$153 | 0.19% | 72 |
|
|
2018
Q1 | $590K | Buy |
11,926
+572
| +5% | +$28.3K | 0.25% | 68 |
|
|
2017
Q4 | $511K | Buy |
11,354
+6,116
| +117% | +$275K | 0.15% | 86 |
|
|
2017
Q3 | $270K | Buy |
5,238
+588
| +13% | +$30.3K | 0.07% | 113 |
|
|
2017
Q2 | $253K | Buy |
4,650
+64
| +1% | +$3.48K | 0.08% | 111 |
|
|
2017
Q1 | $245K | Buy |
+4,586
| New | +$245K | 0.07% | 110 |
|